Pelthos Therapeutics, Inc.

Contributing Author

Recent Articles by Pelthos Therapeutics, Inc.

Dec-04	Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI (berdazimer) Topical Gel, 10.3% PTHS GlobeNewswire
Dec-02	Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference PTHS GlobeNewswire
Nov-13	Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results PTHS GlobeNewswire
Nov-07	Pelthos Therapeutics Acquires Xepi (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing PTHS GlobeNewswire
Nov-05	Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025 PTHS GlobeNewswire
Oct-09	Pelthos Therapeutics Launches Moms Against Molluscum Movement to Unite Families Affected by Molluscum Contagiosum PTHS GlobeNewswire
Sep-08	Pelthos Therapeutics to Participate in Upcoming September Investor Conferences PTHS GlobeNewswire
Sep-02	Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference PTHS GlobeNewswire
Aug-18	Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update PTHS GlobeNewswire